FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series D or later / Health care startups that raised Series D or later in Europe

Health care startups that raised Series D or later in Europe

Updated 16 Nov 2026

Reset
Health care startups that raised Series D or later in Europe
One-time CSV
  • 75 funded companies, 53 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-d-plus~europe.csv75 rows × 18 columns
CompanyCityLast roundAmountDate
bit.bioCambridgeSeries D$25.0M2026-11-04
Leo Cancer CareHarleySeries D$65.0M2026-07-08
CellCentricCambridgeSeries D$220.0M2026-05-06
MedTrace PharmaLyngbySeries F$11.1M2025-05-12
Alentis TherapeuticsAllschwilSeries D$181.4M2024-11-12
CatalYmPlaneggSeries D$150.0M2024-07-16
HumaLondonSeries D$80.0M2024-07-16
SkyCellZürichSeries D$59.0M2024-06-25

8 rows of the CSV in 5 of its 18 columns.

75
Startups
$8.4B
Total raised
11
Funded in the last 12 months
$1.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

15 of 75
15 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Cambridge, United Kingdom Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016
Leo Cancer Care Leo Cancer Care develops radiation therapy technologies that treat cancer in upright patient positions. Health care Harley, United Kingdom Series D $65.0M 2026-07-08 $130.3M Alumni Ventures, EDBI, Serra Ventures +1 11 to 50 2016
CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Cambridge, United Kingdom Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
MedTrace Pharma MedTrace Pharma helps doctors diagnose critically ill patients faster and more accurately. Biotech Lyngby, Denmark Series F $11.1M 2025-05-12 $63.4M European Innovation Council, Vaekstfonden, ATP +1 11 to 50 2015
Alentis Therapeutics Alentis Therapeutics develops novel therapeutics for advanced liver disease and cancer. Biotech Allschwil, Switzerland Series D $181.4M 2024-11-12 Bpifrance, HTGF (High-Tech Gruenderfonds), RA Capital Management +2 51 to 100 2019
CatalYm CatalYm develops immunotherapies to treat cancer. Biotech Planegg, Germany Series D $150.0M 2024-07-16 $260.9M Bayern Kapital, Forbion Capital Partners, Novartis Venture Fund +1 11 to 50 2016
Huma Unicorn Huma offers a health platform for remote patient monitoring and biological data collection in preventive care. Artificial intelligence London, United Kingdom Series D $80.0M 2024-07-16 $322.6M Samsung NEXT, Unilever Ventures, Leaps by Bayer +1 501 to 1,000 2011
SkyCell SkyCell develops temperature-controlled logistics containers for the pharmaceutical industry. Health care Zürich, Switzerland Series D $59.0M 2024-06-25 M&G Investments, MVM Life Science Partners, Tybourne Capital Management +1 101 to 250 2013
Phagenesis Phagenesis develops a device that treats dysphagia, a condition that makes swallowing food unsafe. Biotech Manchester, United Kingdom Series D $42.0M 2024-03-04 $71.4M MedTech Innovator, EQT Life Sciences, Northern Gritstone +2 11 to 50 2007
Lunaphore Lunaphore is a life sciences company that creates technologies enabling spatial biology in all laboratories. Biotech Lausanne, Switzerland Series D $32.7M 2023-03-23 Venture Kick, VentureOut, redalpine 11 to 50 2014
iThera Medical iThera Medical develops proprietary MSOT imaging technology for preclinical and clinical applications. Biotech Munich, Germany Series D $13.8M 2022-12-21 $42.3M European Innovation Council, Bayern Kapital, German Federal Ministry of Research, Technology and Space +1 11 to 50 2010
Kry Unicorn Kry helps patients make active choices about their health alongside healthcare professionals. Health care Stockholm, Sweden Series D $160.0M 2022-07-21 $729.4M Accel, Index Ventures, Creandum +2 1,001 to 5,000 2015
Swile Unicorn Swile provides employee benefits through an all-in-one smartcard and an app. Commerce Paris, France Series D $199.9M 2021-10-11 Bpifrance, Index Ventures, SoftBank +2 501 to 1,000 2018
Biosystems International Biosystems International develops blood-based diagnostics for cancer and chronic diseases. Biotech Debrecen, Hungary Series D $2.8M 2020-10-29 Societe Generale Asset Management, Amundi Private Equity Funds 11 to 50 2004
Phenex Pharmaceuticals Phenex Pharmaceuticals discovers and develops novel pharmaceutical drugs. Biotech Heidelberg, Germany Series D $6.5M 2012-10-31 KfW, Creathor Ventures, LBBW VC +2 11 to 50 2002

Table 1. Health care startups that raised Series D or later in Europe: the 15 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 75.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 CellCentric CellCentric develops small molecule therapies for treating cancer and multiple myeloma. Biotech Cambridge, United Kingdom Series D $220.0M 2026-05-06 $475.7M Innovate UK, 5Y Capital, RA Capital Management +2 11 to 50 2003
2 Leo Cancer Care Leo Cancer Care develops radiation therapy technologies that treat cancer in upright patient positions. Health care Harley, United Kingdom Series D $65.0M 2026-07-08 $130.3M Alumni Ventures, EDBI, Serra Ventures +1 11 to 50 2016
3 bit.bio Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. Biotech Cambridge, United Kingdom Series D $25.0M 2026-11-04 $250.0M Metaplanet, Foresite Capital 101 to 250 2016

Table 2. Health care startups that raised Series D or later in Europe: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Bayern Kapital Venture capital firm Landshut, Germany 5 7%
2 KfW Government investment office Frankfurt, Germany 3 4%
3 RA Capital Management Startup incubator Boston, United States 2 3% 1 CellCentric
4 European Innovation Council Startup accelerator Brussels, Belgium 2 3%
5 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 2 3%
6 Bpifrance Government investment office Maisons-alfort, France 2 3%
7 Novartis Venture Fund Corporate venture arm Basel, Switzerland 2 3%
8 Forbion Capital Partners Private equity firm Naarden, The Netherlands 2 3%
9 MVM Life Science Partners Venture capital firm London, United Kingdom 2 3%
10 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 2 3%
11 Venture Kick Startup incubator Schlieren, Switzerland 2 3%
12 Index Ventures Venture capital firm San Francisco, United States 2 3%
13 MIG Capital Venture capital firm Munich, Germany 2 3%
14 Foresite Capital Private equity firm San Francisco, United States 1 1% 1 bit.bio
15 Metaplanet Venture capital firm Tallinn, Estonia 1 1% 1 bit.bio

Table 3. Health care startups that raised Series D or later in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 41 55% $3.1B
Software 11 15% $2.5B
Hardware 4 5% $70.3M
Fintech 3 4% $1.6B
Artificial intelligence 2 3% $1.7B
Commerce 2 3% $112.7M
Education 1 1% $6.5M

Table 4. Health care startups that raised Series D or later in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series D+ 75 100% $32.7M

Table 5. Health care startups that raised Series D or later in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 21 28%
Switzerland 12 16%
France 11 15%
Germany 11 15%
Belgium 5 7%
The Netherlands 3 4%
Sweden 2 3%
Poland 2 3%
Austria 1 1%
Denmark 1 1%
Ireland 1 1%
Malta 1 1%

Table 6. Health care startups that raised Series D or later in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Paris 7 9%
Cambridge 6 8%
Munich 5 7%
London 4 5%
Manchester 3 4%
Zürich 2 3%
Stockholm 2 3%
Basel 1 1%
Bristol 1 1%
Harley 1 1%
Horw 1 1%
Utrecht 1 1%

Table 7. Health care startups that raised Series D or later in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 9% $25.0M
October 2026 1 9% $134.7M
August 2026 1 9% $25.0M
July 2026 1 9% $65.0M
June 2026 3 27% $678.6M
May 2026 1 9% $220.0M
January 2026 2 18% $246.7M
November 2025 1 9% $115.0M

Table 8. Health care startups that raised Series D or later in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 10 13% $1.4B
2025 4 5% $201.1M
2024 11 15% $992.6M
2023 2 3% $64.9M
2022 6 8% $290.2M
2021 5 7% $458.5M

Table 9. Health care startups that raised Series D or later in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2015 to 2019 15 20%
2010 to 2014 17 23%
Before 2010 43 57%

Table 10. Health care startups that raised Series D or later in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 2 3%
11 to 50 38 53%
51 to 100 8 11%
101 to 250 14 19%
251 to 500 2 3%
501 to 1,000 5 7%
1,001 to 5,000 2 3%
10,001 or more 1 1%

Table 11. Health care startups that raised Series D or later in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Europe whose last round is Series D or later are on the list?
75, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 75 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series D or later in Europe: 75 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Europe

Other sectors that raised Series D or later in Europe

Cite: FundingWatcher, 75 health care companies in Europe whose most recent round is Series D or later, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-d-plus/europe/